Both out-licensing and in-licensing activities remain key components of business development within the biotechnology and pharmaceutical industry. The developer of a product or technology might have the resources to take the product to a particular state of development, such as up to animal studies and toxicology studies, but does not have the resources to take the product through its clinical and regulatory phases, and must partner with another organization to take it through these phases and into the market. To boost internal R&D pipelines with new products, biotechnology and pharmaceutical companies actively search to make acquisitions and form partnerships with developers of new products and technologies. Identification of potential partners with matching in-licensing and out-licensing needs is of crucial importance for the formation of potential alliances.

 

PharmaPlus is experienced in the identification of local regional or global partners for early stage (preclinical- FI/II) therapeutic products and technologies. Next to our broad network we use our proprietary in-house partner search databases for the identification of potential licensees or licensors.

For out-licensing PharmaPlus

• reviews the product or technology
• defines the partner search strategy
• develops a non-confidential teaser
• identifies and contacts potential licensees with matching needs
• obtains feedback from potential licensees contacted
• facilitates discussions between the parties under confidentiality

For in-licensing PharmaPlus

• defines strategic search criteria
• identifies in-licensing opportunities that meet strategic criteria
• obtains feedback from potential licensors on identified opportunities
• evaluates in-licensing opportunities
• presents in-licensing opportunities to client
• facilitates discussions between the parties under confidentiality

Partner searches (both in- and out-licensing) for third party technologies have been performed in the fields of autoimmune disorders, bone disorders, cardiovascular disorders, CNS disorders, dermatology, eye disorders, genetic disorders, infectious diseases, musculoskeletal disorders, oncology, respiratory disorders, transplantation, vaccines, antibody technologies, imaging, specialty generics and diagnostics.